CYTK · Cytokinetics Incorporated Common Stock
View on chartInsiders & Stakes
| Robert I. Blum President & CEO | ▼ Sell | Open Market | 278,544 Shares held | 9/28/2026 | View profile |
| Fady Ibraham Malik EVP Research & Development | ▼ Sell | Open Market | 153,902 Shares held | 10/6/2026 | View profile |
| Cragg David Chief HR & Admin Officer | ▼ Sell | Tax Withholding | 153,233 Shares held | 3/7/2022 | View profile |
| Hessekiel Jeffrey EVP and General Counsel | ▲ Buy | Grant | 107,943 Shares held | 3/15/2026 | View profile |
| SCHLOSSBERG MARK A SVP - Legal & General Counsel | ▼ Sell | Open Market | 103,408 Shares held | 3/15/2022 | View profile |
| John T. Henderson Director | ▲ Buy | Grant | 78,360 Shares held | 7/15/2026 | View profile |
| Sung Lee EVP, Chief Financial Officer | ▼ Sell | Open Market | 63,221 Shares held | 7/1/2026 | View profile |
| Andrew Callos EVP, Chief Commercial Officer | ▼ Sell | Open Market | 58,555 Shares held | 8/31/2026 | View profile |
| Jaw Ching SVP Finance & CFO | ▼ Sell | Tax Withholding | 57,346 Shares held | 3/6/2023 | View profile |
| Wendell Wierenga Director | ▲ Buy | Grant | 35,563 Shares held | 7/15/2026 | View profile |
| Nancy Wysenski Director | ▲ Buy | Grant | 33,992 Shares held | 7/15/2026 | View profile |
| Pletcher Brett A EVP, Chief Legal Officer | ▲ Buy | Grant | 33,140 Shares held | 8/30/2024 | View profile |
| WIERENGA WENDALL Director | ▲ Buy | Grant | 32,345 Shares held | 7/15/2025 | View profile |
| GAGE L PATRICK Director | ▼ Sell | Open Market | 28,932 Shares held | 11/8/2021 | View profile |
| Muna Bhanji Director | ▲ Buy | Grant | 26,361 Shares held | 5/27/2026 | View profile |
| Robert Arthur Harrington Director | ▲ Buy | Grant | 21,932 Shares held | 7/15/2026 | View profile |
| COSTA SANTO J Director | ▲ Buy | Grant | 20,600 Shares held | 5/15/2024 | View profile |
| SMITH SANDFORD D Director | ▲ Buy | Grant | 18,801 Shares held | 1/2/2024 | View profile |
| Wong Robert VP, Chief Accounting Officer | ▲ Buy | Grant | 18,655 Shares held | 12/3/2024 | View profile |
| B. Lynne Parshall Director | ▼ Sell | Open Market | 10,784 Shares held | 9/1/2026 | View profile |
| Edward M. Kaye, MD CEO | ▲ Buy | Grant | 10,434 Shares held | 7/15/2026 | View profile |
| Robert E. Landry EVP Finance CFO | ▼ Sell | Open Market | 8,184 Shares held | 9/15/2026 | View profile |
| Califf Robert Director | ▲ Buy | Grant | 6,003 Shares held | 1/3/2022 | View profile |
| James M. Daly Director | ▲ Buy | Grant | 3,390 Shares held | 7/15/2026 | View profile |
Transaction History
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 10/6/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $215K | 10/6/2026 |
| Robert I. Blum | ▲ Buy | Option Exercise | 7,500 | $80K | 9/28/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $491K | 9/28/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 9/22/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $239K | 9/22/2026 |
| Robert E. Landry | ▼ Sell | Open Market | 1,000 | $72K | 9/15/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 97,926 | $6.8M | 9/15/2026 |
| Robert I. Blum | ▲ Buy | Option Exercise | 7,500 | $80K | 9/14/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $551K | 9/14/2026 |
| Robert I. Blum | ▼ Sell | Gift | 1,350 | $0 | 9/14/2026 |
| Robert I. Blum | ▼ Sell | Gift | 97,926 | $0 | 9/14/2026 |
| Robert I. Blum | ▼ Sell | Gift | 97,926 | $0 | 9/14/2026 |
| Robert E. Landry | ▼ Sell | Open Market | 1,000 | $75K | 9/11/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 9/8/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $264K | 9/8/2026 |
| B. Lynne Parshall | ▼ Sell | Open Market | 5,000 | $357K | 9/1/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 10,000 | $233K | 8/31/2026 |
| Andrew Callos | ▼ Sell | Open Market | 10,000 | $702K | 8/31/2026 |
| Robert I. Blum | ▲ Buy | Option Exercise | 7,500 | $80K | 8/31/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $527K | 8/31/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 8/18/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $265K | 8/18/2026 |
| Robert I. Blum | ▲ Buy | Option Exercise | 7,500 | $80K | 8/10/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $576K | 8/10/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 14,000 | $326K | 7/30/2026 |
| Andrew Callos | ▼ Sell | Open Market | 14,000 | $1.1M | 7/30/2026 |
| Robert I. Blum | ▲ Buy | Option Exercise | 7,500 | $80K | 7/27/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $607K | 7/27/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 7/21/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $282K | 7/21/2026 |
| Nancy Wysenski | ▲ Buy | Grant | 75 | $6K | 7/15/2026 |
| Wendell Wierenga | ▲ Buy | Grant | 75 | $6K | 7/15/2026 |
| Edward M. Kaye, MD | ▲ Buy | Grant | 151 | $12K | 7/15/2026 |
| John T. Henderson | ▲ Buy | Grant | 272 | $22K | 7/15/2026 |
| Robert Arthur Harrington | ▲ Buy | Grant | 151 | $12K | 7/15/2026 |
| James M. Daly | ▲ Buy | Grant | 151 | $12K | 7/15/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 10 | $820 | 7/13/2026 |
| Robert I. Blum | ▲ Buy | Option Exercise | 7,490 | $79K | 7/13/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,490 | $614K | 7/13/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 7/7/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $303K | 7/7/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $637K | 7/1/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 7/1/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,000 | $1.3M | 7/1/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 1,112 | $54K | 7/1/2026 |
| Sung Lee | ▼ Sell | Open Market | 1,112 | $98K | 7/1/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 188 | $8K | 6/29/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 822 | $36K | 6/29/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 1,113 | $54K | 6/29/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 188 | $8K | 6/29/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 823 | $37K | 6/29/2026 |
| Sung Lee | ▼ Sell | Open Market | 3,134 | $266K | 6/29/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 23,370 | $1.1M | 6/24/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 9,307 | $413K | 6/24/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 2,817 | $125K | 6/24/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 1,113 | $54K | 6/24/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 188 | $8K | 6/24/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 822 | $36K | 6/24/2026 |
| Sung Lee | ▲ Buy | Option Exercise | 1,113 | $54K | 6/24/2026 |
| Sung Lee | ▼ Sell | Open Market | 38,730 | $3.2M | 6/24/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $278K | 6/23/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 6/23/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $528K | 6/15/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 6/9/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $238K | 6/9/2026 |
| Edward M. Kaye, MD | ▼ Sell | Open Market | 2,933 | $223K | 6/1/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 6/1/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,000 | $1.1M | 6/1/2026 |
| B. Lynne Parshall | ▼ Sell | Open Market | 5,000 | $370K | 6/1/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $579K | 5/27/2026 |
| Muna Bhanji | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| James M. Daly | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| Robert Arthur Harrington | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| John T. Henderson | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| B. Lynne Parshall | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| Robert E. Landry | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| Wendell Wierenga | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| Nancy Wysenski | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| Edward M. Kaye, MD | ▲ Buy | Grant | 2,851 | $0 | 5/27/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 5/19/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $265K | 5/19/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $584K | 5/14/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 5/5/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $271K | 5/5/2026 |
| Wendell Wierenga | ▲ Buy | Option Exercise | 4,032 | $50K | 5/5/2026 |
| Wendell Wierenga | ▼ Sell | Open Market | 4,032 | $302K | 5/5/2026 |
| Sung Lee | ▼ Sell | Open Market | 23,906 | $1.8M | 5/5/2026 |
| John T. Henderson | ▲ Buy | Option Exercise | 20,000 | $152K | 5/5/2026 |
| John T. Henderson | ▼ Sell | Open Market | 20,000 | $1.5M | 5/5/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 11,333 | $443K | 5/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 11,333 | $875K | 5/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,857 | $1.0M | 5/1/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,857 | $597K | 5/1/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 4/30/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,000 | $949K | 4/30/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $447K | 4/29/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 4/21/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $230K | 4/21/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $490K | 4/15/2026 |
| Nancy Wysenski | ▲ Buy | Grant | 95 | $6K | 4/15/2026 |
| Wendell Wierenga | ▲ Buy | Grant | 95 | $6K | 4/15/2026 |
| Edward M. Kaye, MD | ▲ Buy | Grant | 191 | $12K | 4/15/2026 |
| John T. Henderson | ▲ Buy | Grant | 325 | $21K | 4/15/2026 |
| Robert Arthur Harrington | ▲ Buy | Grant | 191 | $12K | 4/15/2026 |
| James M. Daly | ▲ Buy | Grant | 191 | $12K | 4/15/2026 |
| Andrew Callos | ▼ Sell | Open Market | 7,449 | $492K | 4/15/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 3,500 | $27K | 4/7/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 3,500 | $228K | 4/7/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 1,000 | $65K | 4/7/2026 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 1,000 | $11K | 4/7/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,500 | $500K | 4/1/2026 |
| Andrew Callos | ▼ Sell | Open Market | 3,639 | $237K | 3/31/2026 |
| Andrew Callos | ▼ Sell | Open Market | 1,930 | $120K | 3/18/2026 |
| Andrew Callos | ▼ Sell | Open Market | 5,626 | $350K | 3/17/2026 |
| Sung Lee | ▼ Sell | Open Market | 4,935 | $307K | 3/17/2026 |
| Andrew Callos | ▼ Sell | Open Market | 2,916 | $181K | 3/17/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 7,636 | $475K | 3/17/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 4,397 | $273K | 3/17/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 12,673 | $788K | 3/17/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 23,928 | $1.5M | 3/17/2026 |
| Andrew Callos | ▼ Sell | Open Market | 1,709 | $104K | 3/16/2026 |
| Robert I. Blum | ▲ Buy | Grant | 75,258 | $0 | 3/15/2026 |
| Andrew Callos | ▲ Buy | Grant | 20,646 | $0 | 3/15/2026 |
| Andrew Callos | ▲ Buy | Grant | 13,320 | $0 | 3/15/2026 |
| Hessekiel Jeffrey | ▲ Buy | Grant | 20,646 | $0 | 3/15/2026 |
| Sung Lee | ▲ Buy | Grant | 20,646 | $0 | 3/15/2026 |
| Fady Ibraham Malik | ▲ Buy | Grant | 27,306 | $0 | 3/15/2026 |
| Robert I. Blum | ▼ Sell | Open Market | 7,931 | $482K | 3/9/2026 |
| Andrew Callos | ▼ Sell | Open Market | 2,582 | $157K | 3/9/2026 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 2,907 | $177K | 3/9/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 11,000 | $430K | 3/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,000 | $928K | 3/5/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 3/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 11,000 | $681K | 3/5/2026 |
| B. Lynne Parshall | ▼ Sell | Open Market | 5,000 | $306K | 3/2/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 886 | $33K | 3/2/2026 |
| Andrew Callos | ▼ Sell | Open Market | 886 | $55K | 3/2/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 2/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,000 | $929K | 2/5/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 886 | $33K | 2/2/2026 |
| Andrew Callos | ▼ Sell | Open Market | 886 | $55K | 2/2/2026 |
| Nancy Wysenski | ▲ Buy | Grant | 98 | $6K | 1/15/2026 |
| James M. Daly | ▲ Buy | Grant | 197 | $12K | 1/15/2026 |
| Wendell Wierenga | ▲ Buy | Grant | 98 | $6K | 1/15/2026 |
| Edward M. Kaye, MD | ▲ Buy | Grant | 197 | $12K | 1/15/2026 |
| John T. Henderson | ▲ Buy | Grant | 334 | $21K | 1/15/2026 |
| Robert Arthur Harrington | ▲ Buy | Grant | 197 | $12K | 1/15/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 1/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 15,000 | $904K | 1/5/2026 |
| Andrew Callos | ▼ Sell | Open Market | 913 | $57K | 1/2/2026 |
| Andrew Callos | ▲ Buy | Option Exercise | 885 | $33K | 1/2/2026 |
| Andrew Callos | ▼ Sell | Open Market | 885 | $56K | 1/2/2026 |
| Andrew Callos | ▼ Sell | Open Market | 1,809 | $113K | 12/29/2025 |
| Fady Ibraham Malik | ▲ Buy | Grant | 2,000 | $0 | 12/22/2025 |
| Wendell Wierenga | ▲ Buy | Option Exercise | 20,000 | $152K | 12/22/2025 |
| Wendell Wierenga | ▼ Sell | Open Market | 20,000 | $1.3M | 12/22/2025 |
| Robert I. Blum | ▲ Buy | Grant | 5,765 | $0 | 12/22/2025 |
| Robert I. Blum | ▲ Buy | Grant | 5,765 | $0 | 12/22/2025 |
| Robert I. Blum | ▼ Sell | Tax Withholding | 2,935 | $184K | 12/22/2025 |
| Fady Ibraham Malik | ▲ Buy | Grant | 2,000 | $0 | 12/22/2025 |
| Fady Ibraham Malik | ▼ Sell | Tax Withholding | 1,016 | $64K | 12/22/2025 |
| Andrew Callos | ▲ Buy | Grant | 1,589 | $0 | 12/22/2025 |
| Andrew Callos | ▲ Buy | Grant | 1,588 | $0 | 12/22/2025 |
| Andrew Callos | ▼ Sell | Tax Withholding | 675 | $42K | 12/22/2025 |
| Sung Lee | ▲ Buy | Grant | 2,152 | $0 | 12/22/2025 |
| Sung Lee | ▲ Buy | Grant | 2,152 | $0 | 12/22/2025 |
| Sung Lee | ▼ Sell | Tax Withholding | 805 | $50K | 12/22/2025 |
| Robert I. Blum | ▲ Buy | Option Exercise | 54,727 | $365K | 12/22/2025 |
| Robert I. Blum | ▼ Sell | Tax Withholding | 30,426 | $2.1M | 12/22/2025 |
| Robert I. Blum | ▲ Buy | Option Exercise | 16,506 | $110K | 12/22/2025 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 2,200 | $23K | 12/16/2025 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 2,200 | $135K | 12/16/2025 |
| Andrew Callos | ▲ Buy | Option Exercise | 1,042 | $41K | 12/8/2025 |
| Andrew Callos | ▼ Sell | Open Market | 1,042 | $69K | 12/8/2025 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,000 | $349K | 12/5/2025 |
| Andrew Callos | ▲ Buy | Option Exercise | 11,000 | $430K | 12/5/2025 |
| Andrew Callos | ▲ Buy | Option Exercise | 15,858 | $597K | 12/5/2025 |
| Andrew Callos | ▲ Buy | Option Exercise | 10,628 | $400K | 12/5/2025 |
| Andrew Callos | ▼ Sell | Open Market | 52,486 | $3.5M | 12/5/2025 |
| Sung Lee | ▼ Sell | Tax Withholding | 1,560 | $101K | 12/3/2025 |
| Andrew Callos | ▼ Sell | Tax Withholding | 1,368 | $89K | 12/3/2025 |
| Fady Ibraham Malik | ▼ Sell | Tax Withholding | 2,058 | $134K | 12/3/2025 |
| Robert I. Blum | ▼ Sell | Tax Withholding | 5,930 | $386K | 12/3/2025 |
| John T. Henderson | ▲ Buy | Option Exercise | 8,750 | $88K | 12/2/2025 |
| John T. Henderson | ▼ Sell | Open Market | 8,750 | $559K | 12/2/2025 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 2,200 | $23K | 12/2/2025 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 2,200 | $141K | 12/2/2025 |
| Edward M. Kaye, MD | ▲ Buy | Option Exercise | 8,064 | $100K | 12/1/2025 |
| Edward M. Kaye, MD | ▲ Buy | Option Exercise | 20,000 | $285K | 12/1/2025 |
| Edward M. Kaye, MD | ▼ Sell | Open Market | 28,064 | $1.9M | 12/1/2025 |
| Robert Arthur Harrington | ▼ Sell | Open Market | 2,150 | $144K | 12/1/2025 |
| B. Lynne Parshall | ▼ Sell | Open Market | 5,000 | $324K | 11/19/2025 |
| Fady Ibraham Malik | ▼ Sell | Open Market | 2,200 | $146K | 11/18/2025 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 2,200 | $23K | 11/18/2025 |
| Hessekiel Jeffrey | ▲ Buy | Grant | 87,297 | $0 | 11/14/2025 |
| Edward M. Kaye, MD | ▼ Sell | Open Market | 5,175 | $337K | 11/11/2025 |
| Edward M. Kaye, MD | ▲ Buy | Option Exercise | 5,175 | $50K | 11/11/2025 |
| Robert I. Blum | ▼ Sell | Gift | 2,000 | $0 | 11/5/2025 |
| Fady Ibraham Malik | ▲ Buy | Option Exercise | 2,295 | $24K | 11/4/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Cytokinetics Launches ASPEN-HCM Real-World Study
Cytokinetics has initiated the ASPEN-HCM study to evaluate MYQORZO in real-world patients with symptomatic obstructive hypertrophic cardiomyopathy. The company also announced four upcoming presentations at the HFSA Annual Scientific Meeting 2026. These clinical updates provide new data points for investors, while the stock currently trades near its 52-week low.
Cytokinetics Launches ASPEN-HCM Real-World Study. Cytokinetics has initiated the ASPEN-HCM study to evaluate MYQORZO in real-world patients with symptomatic obstructive hypertrophic cardiomyopathy. The company also announced four upcoming presentations at the HFSA Annual Scientific Meeting 2026. These clinical updates provide new data points for investors, while the stock currently trades near its 52-week low.